AFINITOR® (everolimus) Logo | AFINITOR.com
AFINITOR is a once-daily oral inhibitor of mTOR (mammalian target of rapamycin) for patients with advanced renal cell carcinoma (RCC) whose disease has progressed on or after treatment with VEGF-targeted therapy
Afinitor International Website  |  For Healthcare Professionals Outside the U.S.  |  US Residents

Stay informed on the latest information, including news related to AFINITOR and other updates.